PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New clue into the curious case of our ageing immune system

New clue into the curious case of our ageing immune system
2024-08-14
(Press-News.org)

A WEHI study could help solve a long-standing mystery into why a key immune organ in our bodies shrinks and loses its function as we get older.

The thymus is an organ essential for good health due to its ability to produce special immune cells that are responsible for fighting infections and cancer.

In a world-first, researchers have uncovered new cells that drive this ageing process in the thymus – significant findings that could unlock a way to restore function in the thymus and prevent our immunity from waning as we age.

Watch and embed the video: https://youtu.be/2x1UGqNh77w

At a glance

The thymus is an organ essential for our immune defence but it shrinks and weakens as we get older. The reason for this loss remains a long-standing mystery. A new study has been able to visualise, for the first time, how two cell types drive this ageing process and cause the thymus to lose its function and regeneration abilities over time.  The findings could help uncover a way to stop the thymus from ageing and, critically, develop methods to restore immunity in vulnerable people in the future.


T cells, also known as T lymphocytes, are a type of white blood cell that plays a crucial role in our immune system. T cells are essential for identifying and responding to pathogens, such as viruses and bacteria, and for eliminating infected or cancerous cells. 

The thymus is a small, but mighty, organ that sits behind the breastbone. It is the only organ in the body that can make T cells. 

But a curious feature of the thymus is that it is the first organ in our bodies to shrink as we get older. As this happens, the T cell growth areas in the thymus are replaced with fatty tissue, diminishing T cell production and contributing to a weakened immune system.

While the thymus is capable of regenerating from damage, to date researchers have been unable to figure out how to unlock this ability and boost immunity in humans as we age.

WEHI Laboratory Head Professor Daniel Gray said the new findings, published in Nature Immunology, could help solve this mystery that has stumped researchers for decades.

“The number of new T cells produced in the body significantly declines after puberty, irrespective of how fit you are. By age 65, the thymus has virtually retired,” Prof Gray said.

“This weakening of the thymus makes it harder for the body to deal with new infections, cancers and regulate immunity as we age. 

“This is also why adults who have depleted immune systems, for example due to cancer treatment or stem cell transplants, take much longer than children to recover. 

“These adults need years to recover their T cells – or sometimes never do – putting them at higher risk of contracting potentially life-threatening infections for the rest of their lives.

“Exploring ways to restore thymic function is critical to finding new therapies that can improve outcomes for these vulnerable patients and find a way to ensure a healthy level of T cells are produced throughout our lives.”

The new study, an international collaboration with groups at the Fred Hutch Cancer Center (Seattle) and Memorial Sloan Kettering Cancer Centre (NYC), provides crucial new insights that could help achieve this goal.

“Our discovery provides a new angle for thymic regeneration and immune restoration, could unravel a way to boost immune function in vulnerable patients in the future,” Prof Gray said. 

Scarring effects 

Using advanced imaging techniques at WEHI’s Centre for Dynamic Imaging and animal models, the research team discovered two new cell types that cause the thymus to lose its function.

These cells, which appeared only in the defective thymus of older mice and humans, were found to form clusters around T cell growth areas, impairing the organ’s ability to make these important immune cells. 

In a world-first, the researchers discovered these clusters also formed ‘scars’ in the thymus which prevented the organ from restoring itself after damage. 

Dr Kelin Zhao, who led the imaging efforts, said the findings showed for the first time how this scarring process acts as a barrier to thymic regeneration and function.

“While a large focus of research into thymic loss of function has focused on the shrinking process, we’ve proven that changes that occur inside the organ also impact its ability to function with age,” Dr Zhao said.

“By capturing these cell clusters in the act and showing how they contribute to loss of thymic function, we’ve been able to do something no one else has ever done before, largely thanks to the incredible advanced imaging platforms we have at WEHI.

“This knowledge enables us to investigate whether these cells can be therapeutically targeted in future, to help turn back the clock on the ageing thymus and boost T cell function in humans as we get older. This is the goal our team is working towards.”

Rich WEHI history 

The thymus has deep roots to the institute, with the function of the organ discovered by WEHI Emeritus Professor Jacques Miller in 1958.

While working at the Chester Beatty Research Institute in London, Prof Miller’s work on leukaemia led him to discover that the thymus was crucial to the development of the immune system. He is now credited as the last person to have identified the function of a major organ.

Prof Miller’s discovery revolutionised our understanding of the immune system, infection and disease, with many WEHI researchers – including Prof Daniel Gray’s lab – continuing to build upon his landmark findings.

The new study, “Age-related epithelial defects limit thymic function and regeneration” is published in Nature Immunology (DOI: 10.1038/s41590-024-01915-9) 

This research was supported by National Institutes of Health, the National Health and Medical Research Council (NHMRC), the Cancer Council of Victoria, the Starr Cancer Consortium, the Tri-Institutional Stem Cell Initiative, The Lymphoma Foundation, The Susan and Peter Solomon Divisional Genomics Program, Cycle for Survival, and the Parker Institute for Cancer Immunotherapy and the University of Melbourne Research Training Program Scholarship.

WEHI authors: Kelin Zhao, Michael D’Andrea, Julie Sheridan, Verena Wimmer, Kelly Rogers, Daniel Gray.

 

END


[Attachments] See images for this press release:
New clue into the curious case of our ageing immune system New clue into the curious case of our ageing immune system 2 New clue into the curious case of our ageing immune system 3

ELSE PRESS RELEASES FROM THIS DATE:

Venting your frustrations can make friends like you better – if you do it right

2024-08-14
Key takeaways Venting about your frustrations with one friend to another may feel good, but it doesn’t necessarily reduce anger. Experiments showed that people who listened to a friend vent liked and supported that person more than those who were vented about — but only if the person venting didn’t derogate or seem aggressive toward the other friend. Venting might be an effective tool of competition for listeners’ affections precisely because it is not readily recognized as a tool of competition. Venting about your frustrations with one friend to another isn’t necessarily cathartic, but it can make the friend you’re talking to like and ...

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center

2024-08-14
CLEVELAND – University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the team has shown that it’s feasible to manufacture BAFF CAR T-cells for human subjects. The innovation is introducing genes into T-cells via the process of electroporation in the Wesley Center for Immunotherapy at UH Seidman Cancer Center. In January 2022, a research team from UH Seidman Cancer Center and Case Western Reserve University published a groundbreaking ...

Microscopic packets could deliver diabetes-preventing therapeutics

2024-08-14
Within each of us lies an army of cells whose topmost duty is protecting against external pathogens and internal threats such as proliferating cancer cells. Yet, immune cells can sometimes erroneously attack the body, causing autoimmune diseases like type 1 diabetes. Texas A&M researchers recently received an RO1 grant from the National Institutes of Health to develop a strategy to deliver immune-suppressing proteins generally produced by specialized stem cells. Such an approach could potentially help reduce the immune system's attack on the insulin-producing beta-cells in the pancreas and open doors to a novel treatment for type 1 diabetes. "We are excited that the ...

New brain-computer interface allows man with ALS to ‘speak’ again

New brain-computer interface allows man with ALS to ‘speak’ again
2024-08-14
A new brain-computer interface (BCI) developed at UC Davis Health translates brain signals into speech with up to 97% accuracy — the most accurate system of its kind. The researchers implanted sensors in the brain of a man with severely impaired speech due to amyotrophic lateral sclerosis (ALS). The man was able to communicate his intended speech within minutes of activating the system. A study about this work was published today in the New England Journal of Medicine. ALS, also known as Lou Gehrig's disease, affects the nerve cells that control movement ...

International study detects consciousness in unresponsive patients

2024-08-14
New research co-led by experts at Mass General Brigham found that brain scans can detect consciousness in some patients with brain injury who are unresponsive. In the study, 241 participants with severe brain injury who do not respond when given a simple instruction were assessed with functional MRI (fMRI), electroencephalography (EEG), or both tests. During these tests, participants heard instructions, such as “imagine opening and closing your hand” followed, 15-30 seconds later by “stop imagining opening and closing your hand.” The fMRI and EEG brain ...

Manard chosen for Society of Applied Spectroscopy’s Lester W. Strock Award

Manard chosen for Society of Applied Spectroscopy’s Lester W. Strock Award
2024-08-14
Benjamin Manard, an analytical chemist in the Chemical Sciences Division of the Department of Energy’s Oak Ridge National Laboratory, will receive the 2024 Lester W. Strock Award from the Society of Applied Spectroscopy. The prize is named for the late Lester W. Strock, a crystal chemist and pioneer in applied spectroscopy. The annual award recognizes researchers who produce outstanding publications in analytical atomic spectrochemistry. “Manard’s publications over the last five years demonstrate a clear focus on the elemental and isotopic analysis of nuclear materials using a variety ...

Patients with unexplainable chronic itch have unique blood biomarkers that could eventually lead to new targeted treatments

2024-08-14
Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause – a condition known as chronic pruritus of unknown origin (CPUO) – that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms. Findings were recently published in the journal Scientific Reports. “Our study found a distinct deficit in certain metabolite ...

Unveiling the brain's reward circuitry

Unveiling the brains reward circuitry
2024-08-14
PHILADELPHIA (August 14, 2024) – A research team – co-led by Penn Nursing – has made a significant breakthrough in understanding the complex neural circuitry underlying reward and addiction by identifying 34 distinct subtypes of medium spiny neurons (MSNs) in the nucleus accumbens (NAc), a key brain region involved in pleasure and motivation. The findings, published in the journal Scientific Reports by Nature, offer insights into the diversity of these neurons and their potential roles in substance ...

Do people with high blood pressure have a higher risk of Alzheimer’s disease?

2024-08-14
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, AUGUST 14, 2024 MINNEAPOLIS – People 60 and older with untreated high blood pressure may have an increased risk of Alzheimer’s disease compared to both people who have been or are being treated for high blood pressure as well as people without the chronic condition. The new research, a meta-analysis, is published in the August 14, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that untreated high blood pressure causes Alzheimer’s disease, they only show ...

Good news for people with MS—COVID-19 vaccine not tied to relapse

2024-08-14
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, AUGUST 14, 2024 MINNEAPOLIS – People with multiple sclerosis (MS) have an increased risk of severe coronavirus infection, but there has been concern regarding potential relapse after vaccination. A new study finds that people with MS may not have a higher risk of relapse after COVID-19 vaccination. The study is published in the August 14, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. “People with MS have an increased risk of severe ...

LAST 30 PRESS RELEASES:

Sensitive ceramics for soft robotics

Trends in hospitalizations and liver transplants associated with alcohol-induced liver disease

Spinal cord stimulation vs medical management for chronic back and leg pain

Engineered receptors help the immune system home in on cancer

How conflicting memories of sex and starvation compete to drive behavior

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

Novel SOURCE study examining development of early COPD in ages 30 to 55

NRL completes development of robotics capable of servicing satellites, enabling resilience for the U.S. space infrastructure

Clinical trial shows positive results for potential treatment to combat a challenging rare disease

New research shows relationship between heart shape and risk of cardiovascular disease

Increase in crisis coverage, but not the number of crisis news events

New study provides first evidence of African children with severe malaria experiencing partial resistance to world’s most powerful malaria drug

Texting abbreviations makes senders seem insincere, study finds

Living microbes discovered in Earth’s driest desert

Artemisinin partial resistance in Ugandan children with complicated malaria

When is a hole not a hole? Researchers investigate the mystery of 'latent pores'

ETRI, demonstration of 8-photon qubit chip for quantum computation

Remote telemedicine tool found highly accurate in diagnosing melanoma

New roles in infectious process for molecule that inhibits flu

Transforming anion exchange membranes in water electrolysis for green hydrogen production

AI method can spot potential disease faster, better than humans

A development by Graz University of Technology makes concreting more reliable, safer and more economical

Pinpointing hydrogen isotopes in titanium hydride nanofilms

Political abuse on X is a global, widespread, and cross-partisan phenomenon, suggests new study

Reintroduction of resistant frogs facilitates landscape-scale recovery in the presence of a lethal fungal disease

Scientists compile library for evaluating exoplanet water

Updated first aid guidelines enhance care for opioid overdose, bleeding, other emergencies

Revolutionizing biology education: Scientists film ‘giant’ mimivirus in action

Genetic variation enhances cancer drug sensitivity

Protective genetic mutation offers new hope for understanding autism and brain development

[Press-News.org] New clue into the curious case of our ageing immune system